Long‐Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment by Alten, Rieke, Kaine, Jeffrey, Keystone, Edward, Nash, Peter, Delaet, Ingrid, Genovese, Mark C.

Get full text

Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program by WEINBLATT, Michael E, MORELAND, Larry W, HOCHBERG, Marc C, WESTHOVENS, Rene, COHEN, Roger B, KELLY, Sheila M, KHAN, Nader, PAPPU, Ramesh, DELAET, Ingrid, LUO, Allison, GUJRATHI, Sheila

Get full text

Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase II... by Nash, Peter, Nayiager, Sauithree, Genovese, Mark C., Kivitz, Alan J., Oelke, Kurt, Ludivico, Charles, Palmer, William, Rodriguez, Cristian, Delaet, Ingrid, Elegbe, Ayanbola, Corbo, Michael

Get full text

Subcutaneous abatacept for the treatment of rheumatoid arthritis: longterm data from the ACQUIRE trial by Genovese, Mark C, Tena, César Pacheco, Covarrubias, Arturo, Leon, Gustavo, Mysler, Eduardo, Keiserman, Mauro, Valente, Robert, Nash, Peter, Simon-Campos, J Abraham, Box, Jane, Legerton, 3rd, Clarence William, Nasonov, Evgeny, Durez, Patrick, Delaet, Ingrid, Teng, Julie, Alten, Rieke

Get full text

Subcutaneous Abatacept for the Treatment of Rheumatoid Arthritis: Longterm Data from the ACQUIRE Trial by GENOVESE, Mark C, TENA, César Pacheco, LEGERTON, Clarence William, NASONOV, Evgeny, DUREZ, Patrick, DELAET, Ingrid, TENG, Julie, ALTEN, Rieke, COVARRUBIAS, Arturo, LEON, Gustavo, MYSLER, Eduardo, KEISERMAN, Mauro, VALENTE, Robert, NASH, Peter, SIMON-CAMPOS, J. Abraham, BOX, Jane

Get full text